Rapid Micro Biosystems (RPID) Net Cash Flow (QoQ) (2020 - 2026)
Rapid Micro Biosystems (RPID) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.59 Bn | 176.29 Bn | 6.27 Bn |
| 2 | Stryker | 129.07 Bn | 126.19 Bn | 3.81 Bn |
| 3 | Medtronic | 108.58 Bn | 99.36 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.64 Bn | 67.19 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.38 Bn | 44.71 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.13 Bn | 25.84 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.27 Bn | 21.15 Bn | 2.07 Bn |
| 10 | Rapid Micro Biosystems | 90.19 Mn | 80.75 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -673.34% |
| Dec 31, 2025 | 76.84% |
| Sep 30, 2025 | 193.73% |
| Jun 30, 2025 | -132.78% |
| Mar 31, 2025 | 139.49% |
| Dec 31, 2024 | 66.49% |
| Sep 30, 2024 | -202.65% |
| Jun 30, 2024 | 893.09% |
| Mar 31, 2024 | -471.14% |
| Dec 31, 2023 | 110.20% |
| Sep 30, 2023 | -214.61% |
| Jun 30, 2023 | 260.89% |
| Mar 31, 2023 | -315.42% |
| Dec 31, 2022 | 105.16% |
| Sep 30, 2022 | -86.90% |
| Jun 30, 2022 | 88.97% |
| Mar 31, 2022 | -181.27% |
| Dec 31, 2021 | -134.47% |
| Sep 30, 2021 | 1,522.43% |
| Jun 30, 2021 | -110.70% |